2023
DOI: 10.1016/j.ahj.2022.11.016
|View full text |Cite
|
Sign up to set email alerts
|

International randomized trial on the effect of revascularization or optimal medical therapy of chronic total coronary occlusions with myocardial ischemia - ISCHEMIA-CTO trial – rationale and design

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
10
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
8
1

Relationship

3
6

Authors

Journals

citations
Cited by 13 publications
(10 citation statements)
references
References 23 publications
0
10
0
Order By: Relevance
“…However, using myocardial functional parameters as the indication to perform CTO PCI remains debated due to the limited evidence of improving hard outcomes [ 3 , 29 ] and the lack of cut-off values of ischemia and viability quantification in patients with CTO. The CARISMA_CTO study [ 30 ] and the ongoing ISCHEMIA-CTO trial [ 31 ] can provide more definitive answers in this area shortly.…”
Section: Resultsmentioning
confidence: 99%
“…However, using myocardial functional parameters as the indication to perform CTO PCI remains debated due to the limited evidence of improving hard outcomes [ 3 , 29 ] and the lack of cut-off values of ischemia and viability quantification in patients with CTO. The CARISMA_CTO study [ 30 ] and the ongoing ISCHEMIA-CTO trial [ 31 ] can provide more definitive answers in this area shortly.…”
Section: Resultsmentioning
confidence: 99%
“…A O-15-H 2 O positron emission tomography scan showed severe hypo-perfusion in the RCA territory. With a Seattle Angina Questionnaire Quality of Life score of 50 out of 100, she fulfilled the criteria for inclusion in the Ischemia CTO trial and she was randomized to PCI of the RCA CTO [ 6 ]. Electrocardiogram (ECG) showed sinus rhythm with a long QT interval (QTc corrected by Bazett's and Fridericia's formula of 521 ms and 495 ms, respectively) which was known for several years (Fig.…”
Section: Case Reportmentioning
confidence: 99%
“…Several studies are currently being conducted on the benefits of the procedure. The ISCHEMIA-CTO trial is designed to assess, whether percutaneous revascularization improves quality of life (QoL) and MACE in CTO patients after 6 months [74]. This study may answer questions about whether recanalization of the total occluded coronary artery improves prognosis in asymptomatic patients and/or relieve symptoms in the symptomatic group.…”
Section: Indicationsmentioning
confidence: 99%